Enrish Pharmaceutical Private Limited

Enrish Pharmaceutical Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U74999MH2016PTC280805 Incorporated 07 May 2016 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2024
₹1.03 Cr
▲ 70% YoY
Net profit · FY 2024
₹1.88 Lakh
Net margin 1.8%
EBITDA · FY 2024
₹2.87 Lakh
EBITDA margin 2.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹8 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
4
As per MCA filings

About Enrish Pharmaceutical Private Limited

Data last updated:

Enrish Pharmaceutical Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 May 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC280805. Its GSTIN is 27AAECE2708E1ZZ (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sushant Sudhir Bala and Vijaykumar Shankarrao Moon.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat No A 102 Gurudarshan Apartme Shreya Building Nandivali Dombivali East Kalyan Tahne, Thane, Maharashtra, India – 421201.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.03 Cr, a growth of 70% compared to the previous year. For the same year it recorded a net profit of ₹1.88 Lakh (net margin 1.8%) and EBITDA of ₹2.87 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 121% over three years and 44% over five years.

As per MCA filings, the company has open charges of ₹8 Lakh on record.

Enrish Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0177242). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74999MH2016PTC280805
Registration Number 280805
Incorporation Date 07 May 2016
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0177242

Recognitions & Rankings of Enrish Pharmaceutical

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MH-33-0177242

Contact details

Enrish Pharmaceutical Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Flat No A 102 Gurudarshan Apartme Shreya Building Nandivali Dombivali East Kalyan Tahne, Thane, Maharashtra, India – 421201
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Enrish Pharmaceutical Private Limited, buy the company report.

Comprehensive company report
Enrish Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Enrish Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Enrish Pharmaceutical Private Limited, buy the company report.

Financials of Enrish Pharmaceutical Private Limited

FY 2024 filings available

Enrish Pharmaceutical Private Limited reported revenue of ₹1.03 Cr (up 70% YoY) for FY 2024.

Revenue · FY 2024
₹1.03 Cr ▲ 70%
Net profit · FY 2024
₹1.88 Lakh margin 1.8%
EBITDA · FY 2024
₹2.87 Lakh margin 2.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 70%
3 years · compounded
▲ 121%
5 years · compounded
▲ 44%
EBITDA CAGR growth
1 year
▲ 78%
3 years · compounded
▲ 48%
5 years · compounded
▲ 70%

Revenue has grown at a compounded annual rate (CAGR) of 44% over five years, including 70% growth in the latest year. EBITDA rose 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.87 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.88 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin2.8%
Net Profit Margin1.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Enrish Pharmaceutical Private Limited, buy the company report.

Board of directors of Enrish Pharmaceutical Private Limited

Enrish Pharmaceutical has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sushant Sudhir BalaDirector03 Feb 20224 Years 9 MonthsCurrent
Vijaykumar Shankarrao MoonDirector03 Feb 20224 Years 9 MonthsCurrent
Manishkumar Gunjeshnari MishraDirector07 May 201610 Years 6 MonthsCurrent
Shrikant Sundar RaneDirector01 Dec 20169 Years 11 MonthsCurrent

Auditor

Enrish Pharmaceutical Private Limited is audited by A S Gadiya and Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
A S Gadiya and AssociatesFY 2023156763

Shareholding

The shareholding of Enrish Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Enrish Pharmaceutical Private Limited, buy the company report.

Charges & borrowings

Open charges
₹8 Lakh
Satisfied charges
None
Breakdown by lending institutions
Punjab and Maharashtra Co-Operative Bank Limited₹0.08 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Mar 2018100169630Punjab and Maharashtra Co-Operative Bank Limited₹5 LakhOpen
30 Mar 2017100090081Punjab and Maharashtra Co-Operative Bank Limited₹3 LakhOpen

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Enrish Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Enrish Pharmaceutical has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAECE2708E1ZZMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Enrish Pharmaceutical Private Limited, buy the company report.

Recent activity

Enrish Pharmaceutical Private Limited has 9 board changes on record since 2016: 4 appointments and 5 cessations. The latest: Shrikant Sundar Rane ceased to be Director on 19 Jun 2025.

Ceased
Shrikant Sundar Rane ceased to be Director.
AGM
Enrish Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Sushant Sudhir Bala ceased to be Additional Director.
Ceased
Vijaykumar Shankarrao Moon ceased to be Additional Director.
Filing
Enrish Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Appointed
Sushant Sudhir Bala was appointed as Director.
Appointed
Vijaykumar Shankarrao Moon was appointed as Director.
Ceased
Anil Parmal Singh ceased to be Director.
Charges
A charge with Punjab And Maharashtra Co-Operative Bank Limited amounted to Rs. 5.00 Lakh with Charge ID 100169630 was registered on 28 Mar 2018.
Charges
A charge with Punjab And Maharashtra Co-Operative Bank Limited amounted to Rs. 3.00 Lakh with Charge ID 100090081 was registered on 30 Mar 2017.
Ceased
Dharamendra Ashok Mishra ceased to be Director.
Appointed
Shrikant Sundar Rane was appointed as Director.

2 earlier events are in the company report.

Frequently asked questions

Enrish Pharmaceutical is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 May 2016 (10+ years old) and is registered under CIN U74999MH2016PTC280805.

Enrish Pharmaceutical has 4 current directors:

The latest financial statements of Enrish Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Enrish Pharmaceutical is 27AAECE2708E1ZZ, registered in Maharashtra.

The CIN (Corporate Identification Number) of Enrish Pharmaceutical is U74999MH2016PTC280805. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Enrish Pharmaceutical was incorporated on 07 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.

Shrikant Sundar Rane ceased to be Director on 19 Jun 2025. Sushant Sudhir Bala ceased to be Additional Director on 29 Sep 2024. Vijaykumar Shankarrao Moon ceased to be Additional Director on 29 Sep 2024. Enrish Pharmaceutical has 9 board changes on record in total.

Yes, Enrish Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0177242).

The registered office of Enrish Pharmaceutical is at Flat No A 102 Gurudarshan Apartme Shreya Building Nandivali Dombivali East Kalyan Tahne, Thane, Maharashtra, India – 421201.

Enrish Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.